Examples
| Brand Name | Chemical Name |
| Novantrone | mitoxantrone |
Mitoxantrone is given as an intravenous (IV) injection.
How It Works
Mitoxantrone belongs to a group of medications that interfere with the growth of the cancer cells (antineoplastics). It is used to treat some kinds of cancer.
Why It Is Used
Mitoxantrone is used to treat acute myelogenous leukemia (AML) and non-Hodgkin's lymphoma (NHL). It may also be used to treat other kinds of cancer. Mitoxantrone is also used to treat multiple sclerosis.
How Well It Works
Mitoxantrone is an effective treatment for non-Hodgkin's lymphoma and acute myelogenous leukemia. It also reduces the frequency of relapses of multiple sclerosis.
Side Effects
Side effects of mitoxantrone are common and can include:
- Nausea or vomiting.
- Hair loss.
- Damage to the muscle of the heart. This can be serious.
- Increased risk of infections, especially urinary tract infections.
- Changes in a woman's menstrual cycle.
- Mouth sores (stomatitis).
- Diarrhea or constipation.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
Mitoxantrone should be administered only under the supervision of a medical oncologist, hematologist, or neurologist.
Mitoxantrone may cause serious, even fatal, heart damage in some people. Frequent tests are needed to monitor heart function while taking this medication.
Mitoxantrone can affect your ability to have children. You may not be able to become pregnant or father a child after taking mitoxantrone. Discuss fertility with your doctor before starting treatment with this drug.
Mitoxantrone can cause birth defects. Do not use this medication if you are pregnant or wish to become pregnant or father a child while you are taking it.
Women who take this medication may experience menopausal symptoms, including hot flashes and vaginal dryness.
Complete the new medication information form (PDF)
(What is a PDF document?) to help you understand this medication.
Credits
| Author | Kathe Gallagher, MSW |
| Editor | Alison Allen |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | Joseph O'Donnell, MD - Hematology/Oncology |
| Last Updated | November 30, 2006 |
© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.